AMETOP

This brand name is authorized in Canada, Ireland, New Zealand, South Africa, UK.

Active ingredients

The drug AMETOP contains one active pharmaceutical ingredient (API):

1	Tetracaine UNII 5NF5D4OPCI - TETRACAINE HYDROCHLORIDE
	Tetracaine is a local anaesthetic and is believed to act by blocking nerve conduction mainly by inhibiting sodium ion flux across the axon membrane.
	Read more about Tetracaine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AMETOP 4% w/w Gel	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D04AB06	Tetracaine	D Dermatologicals → D04 Antipruritics, incl. antihistamines, anesthetics, etc. → D04A Antipruritics, incl. antihistamines, anesthetics, etc. → D04AB Anesthetics for topical use
Discover more medicines within D04AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02230575
GB	Medicines & Healthcare Products Regulatory Agency	37186, 89689, 89690
NZ	Medicines and Medical Devices Safety Authority	7884
ZA	Health Products Regulatory Authority	31/4/0157